Insideraktier | 12.988.695 shares |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Netto antal insidere, der køber (rang)
N/A
Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).
Procent af float købt af insidere (rangering)
N/A
Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.
Insiderhandelsdiagram
BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder t insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
---|
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i PHGE.U / BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder t. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i PHGE.U / BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder t. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-04-21 | 2025-04-14 | 4/A | Bassan Merav | PHGE | Common Stock | D | 79.597 | 79.597 | ||||||
2025-04-21 | 2025-04-14 | 4/A | Solomon Jonathan Eitan | PHGE | Common Stock | D | 126.748 | 126.748 | ||||||
2025-04-21 | 2025-04-14 | 4/A | Wolfson Marina | PHGE | Common Stock | D | 68.545 | 68.545 | ||||||
2025-04-18 | 2025-04-14 | 4 | Solomon Jonathan Eitan | PHGE | Common Stock | D | 126.748 | 126.748 | ||||||
2025-04-18 | 2025-04-14 | 4 | Bassan Merav | PHGE | Common Stock | D | 79.597 | 79.597 | ||||||
2025-04-18 | 2025-04-14 | 4 | Wolfson Marina | PHGE | Common Stock | D | 68.545 | 68.545 | ||||||
2025-03-04 | 2024-07-15 | 5 | Cystic Fibrosis Foundation | PHGE | Common Stock, par value $0.0001 per share | D | 854.700 | 1.787.758 | ||||||
2025-03-03 | 2025-02-27 | 4 | Flynn James E Through Deerfield Healthcare Innovations Fund II, L.P. | PHGE | Common Stock | I | 0,9306 | 353.249 | 329 | 1.247.054 | ||||
2025-03-03 | 2025-02-27 | 4 | Flynn James E Through Deerfield Private Design Fund V, L.P. | PHGE | Common Stock | I | 0,9306 | 353.249 | 329 | 1.247.054 | ||||
2024-09-18 | 2024-09-16 | 4 | Bassan Merav | PHGE | Common Stock | D | 31.749 | 31.749 | ||||||
2024-09-18 | 2024-09-16 | 4 | Oron Assaf | PHGE | Common Stock | D | 25.804 | 25.804 | ||||||
2024-09-18 | 2024-09-16 | 4 | Solomon Jonathan Eitan | PHGE | Common Stock | D | 50.556 | 53.056 | ||||||
2024-07-17 | 2024-07-15 | 4 | Flynn James E Through Deerfield Private Design Fund V, L.P. | PHGE | Common Stock | I | 5.883.000 | 8.938.049 | ||||||
2024-07-17 | 2024-07-15 | 4 | Flynn James E Through Deerfield Healthcare Innovations Fund II, L.P. | PHGE | Common Stock | I | 5.883.000 | 8.938.049 | ||||||
2024-05-20 | 2024-05-15 | 4 | OrbiMed Israel BioFund GP Limited Partnership See footnotes | PHGE | Common Stock | I | 0,3812 | -24.344 | -9 | 13.773.653 | ||||
2024-05-20 | 2024-05-15 | 4 | OrbiMed Israel BioFund GP Limited Partnership See footnotes | PHGE | Common Stock | I | 0,2440 | 9.280.408 | 2.264 | 13.797.997 | ||||
2024-05-17 | 2024-05-15 | 4 | Cystic Fibrosis Foundation | PHGE | Common Stock, par value $0.0001 per share | D | 0,0010 | 4.778.265 | 5 | 9.330.580 | ||||
2024-03-26 | 3 | Cystic Fibrosis Foundation | PHGE | Common Stock, par value $0.0001 per share | D | 4.552.315 | ||||||||
2024-03-19 | 2024-03-15 | 4 | Flynn James E Through Deerfield Healthcare Innovations Fund II, L.P. | PHGE | Common Stock | I | 3.055.049 | 3.055.049 | ||||||
2024-03-19 | 2024-03-15 | 4 | Flynn James E Through Deerfield Private Design Fund V, L.P. | PHGE | Common Stock | I | 3.055.049 | 3.055.049 | ||||||
2023-12-01 | 2023-11-29 | 4 | Oron Assaf | PHGE | Common Stock | D | 0,3400 | -2.056 | -1 | 0 | ||||
2023-12-01 | 2023-11-29 | 4 | Oron Assaf | PHGE | Common Stock | D | 0,3500 | -3.414 | -1 | 2.056 | ||||
2023-12-01 | 2023-11-29 | 4 | Oron Assaf | PHGE | Common Stock | D | 0,4000 | -5.444 | -2 | 5.470 | ||||
2023-05-24 | 2023-05-22 | 4 | Oron Assaf | PHGE | Common Stock | D | 0,2731 | 3.192 | 1 | 10.914 | ||||
2023-05-22 | 2023-05-19 | 4 | Oron Assaf | PHGE | Common Stock | D | 0,2809 | 6.521 | 2 | 7.722 | ||||
2023-05-22 | 2023-05-18 | 4 | Oron Assaf | PHGE | Common Stock | D | 0,2727 | 1.201 | 0 | 1.201 | ||||
2023-03-17 | 2023-02-27 | 4 | OrbiMed Israel BioFund GP Limited Partnership See Footnotes | PHGE | Common Stock | I | 0,2450 | 348.000 | 85 | 3.161.489 | ||||
2022-11-14 | 2022-11-04 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,3780 | -1.501 | -1 | 2.997.025 | ||||
2022-11-14 | 2022-11-03 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,3660 | -2.000 | -1 | 2.998.526 | ||||
2022-11-14 | 2022-11-02 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,3590 | -2.416 | -1 | 3.000.526 | ||||
2022-11-14 | 2022-11-01 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,3640 | -1.300 | -0 | 3.002.942 | ||||
2022-11-14 | 2022-10-31 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,3710 | -3.300 | -1 | 3.004.242 | ||||
2022-11-14 | 2022-10-28 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,3560 | -1.526 | -1 | 3.007.542 | ||||
2022-11-14 | 2022-10-27 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,3640 | -1.505 | -1 | 3.009.068 | ||||
2022-11-14 | 2022-10-26 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,3460 | -12.500 | -4 | 3.010.573 | ||||
2022-11-14 | 2022-10-25 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,3650 | -3.072 | -1 | 3.023.073 | ||||
2022-11-14 | 2022-10-24 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,3490 | -5.900 | -2 | 3.026.145 | ||||
2022-11-14 | 2022-10-21 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,3700 | -5.400 | -2 | 3.032.045 | ||||
2022-11-14 | 2022-10-20 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,3740 | -6.636 | -2 | 3.037.445 | ||||
2022-11-14 | 2022-10-19 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,3670 | -4.501 | -2 | 3.044.081 | ||||
2022-11-14 | 2022-10-18 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,3460 | -15.300 | -5 | 3.048.582 | ||||
2022-11-14 | 2022-10-17 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,3350 | -8.098 | -3 | 3.063.882 | ||||
2022-11-14 | 2022-10-14 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,3310 | -3.420 | -1 | 3.071.980 | ||||
2022-11-14 | 2022-10-13 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,3300 | -11.314 | -4 | 3.075.400 | ||||
2022-11-14 | 2022-10-12 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,3330 | -9.700 | -3 | 3.086.714 | ||||
2022-11-14 | 2022-10-11 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,3320 | -5.988 | -2 | 3.096.414 | ||||
2022-11-14 | 2022-10-10 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,3260 | -10.043 | -3 | 3.102.402 | ||||
2022-11-14 | 2022-10-07 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,3580 | -24.708 | -9 | 3.112.445 | ||||
2022-11-14 | 2022-10-06 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,4440 | -25.098 | -11 | 3.137.153 | ||||
2022-11-14 | 2022-10-05 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,4350 | -46.785 | -20 | 3.162.251 | ||||
2022-11-14 | 2022-10-04 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,3440 | -19.200 | -7 | 3.209.036 | ||||
2022-11-14 | 2022-10-03 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,3300 | -15.022 | -5 | 3.228.236 | ||||
2022-11-14 | 2022-09-30 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,3560 | -8.662 | -3 | 3.243.258 | ||||
2022-11-14 | 2022-09-29 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,3490 | -3.300 | -1 | 3.251.920 | ||||
2022-11-14 | 2022-09-28 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,3330 | -15.649 | -5 | 3.255.220 | ||||
2022-11-14 | 2022-09-27 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,3310 | -4.866 | -2 | 3.270.869 | ||||
2022-11-14 | 2022-09-26 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,3550 | -17.528 | -6 | 3.275.735 | ||||
2022-11-14 | 2022-09-23 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,3740 | -5.306 | -2 | 3.293.263 | ||||
2022-11-14 | 2022-09-22 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,4130 | -17.388 | -7 | 3.298.569 | ||||
2022-11-14 | 2022-09-21 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,4270 | -5.574 | -2 | 3.315.957 | ||||
2022-11-14 | 2022-09-20 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,4510 | -10.626 | -5 | 3.321.531 | ||||
2022-11-14 | 2022-09-19 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,4850 | -13.870 | -7 | 3.332.157 | ||||
2022-11-14 | 2022-09-16 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,5130 | -3.200 | -2 | 3.346.027 | ||||
2022-11-14 | 2022-09-15 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,5310 | -3.900 | -2 | 3.349.227 | ||||
2022-11-14 | 2022-09-14 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,5230 | -2.301 | -1 | 3.353.127 | ||||
2022-11-14 | 2022-09-13 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,5250 | -2.201 | -1 | 3.335.428 | ||||
2022-11-14 | 2022-09-12 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,5410 | -1.700 | -1 | 3.357.629 | ||||
2022-11-14 | 2022-09-09 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,5180 | -13.219 | -7 | 3.359.329 | ||||
2022-11-14 | 2022-09-08 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,5220 | -4.592 | -2 | 3.372.548 | ||||
2022-11-14 | 2022-09-07 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,5280 | -8.846 | -5 | 3.377.140 | ||||
2022-11-14 | 2022-09-06 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,5450 | -6.403 | -3 | 3.385.986 | ||||
2022-11-14 | 2022-09-02 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,5460 | -2.001 | -1 | 3.392.389 | ||||
2022-11-14 | 2022-09-01 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,5460 | -8.297 | -5 | 3.394.390 | ||||
2022-11-14 | 2022-08-31 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,5490 | -4.540 | -2 | 3.402.687 | ||||
2022-11-14 | 2022-08-30 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,5660 | -13.487 | -8 | 3.407.227 | ||||
2022-11-14 | 2022-08-29 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,5710 | -11.533 | -7 | 3.420.714 | ||||
2022-11-14 | 2022-08-26 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,6160 | -60.628 | -37 | 3.432.247 | ||||
2022-11-14 | 2022-08-25 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,7180 | -26.945 | -19 | 3.492.875 | ||||
2022-11-14 | 2022-08-24 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,6520 | -8.665 | -6 | 3.519.820 | ||||
2022-11-14 | 2022-08-23 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,6380 | -5.900 | -4 | 3.528.485 | ||||
2022-11-14 | 2022-08-22 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,6570 | -5.000 | -3 | 3.534.385 | ||||
2022-11-14 | 2022-08-19 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,6390 | -14.600 | -9 | 3.539.385 | ||||
2022-11-14 | 2022-08-18 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,6830 | -7.764 | -5 | 3.553.985 | ||||
2022-11-14 | 2022-08-17 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,6880 | -21.335 | -15 | 3.561.749 | ||||
2022-11-14 | 2022-08-16 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,7290 | -8.563 | -6 | 3.583.084 | ||||
2022-11-14 | 2022-08-15 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,7470 | -7.200 | -5 | 3.591.647 | ||||
2022-11-14 | 2022-08-12 | 4 | Ugwumba Chidozie By Symbiosis, LLC | PHGE | Common Stock | I | 0,7340 | -11.406 | -8 | 3.598.847 | ||||
2022-11-14 | 2022-08-11 | 4 | Ugwumba Chidozie By Symbiosis, LLC | PHGE | Common Stock | I | 0,7440 | -9.824 | -7 | 3.610.253 | ||||
2022-11-14 | 2022-08-10 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0,7400 | -17.769 | -13 | 3.620.077 | ||||
2022-03-31 | 2022-03-29 | 4 | GROSSMAN JONAS | PHGE | Common Stock Options - Right to Buy | D | 1,41 | 20.500 | 20.500 | |||||
2022-03-31 | 2022-03-29 | 4 | Sullivan Lynne Marie | PHGE | Common Stock Options - Right to Buy | D | 1,41 | 20.500 | 20.500 | |||||
2022-03-31 | 2022-03-29 | 4 | Amusa Gbolahan | PHGE | Common Stock Options - Right to Buy | D | 1,41 | 20.500 | 20.500 | |||||
2022-03-31 | 2022-03-29 | 4 | Greig Russell | PHGE | Common Stock Options - Right to Buy | D | 1,41 | 41.000 | 41.000 | |||||
2022-03-31 | 2022-03-29 | 4 | Wolfson Marina | PHGE | Common Stock Options - Right to Buy | D | 1,41 | 50.000 | 50.000 | |||||
2022-03-31 | 2022-03-29 | 4 | Solomon Jonathan Eitan | PHGE | Common Stock Options - Right to Buy | D | 1,41 | 205.000 | 205.000 | |||||
2022-03-31 | 2022-03-29 | 4 | Bassan Merav | PHGE | Common Stock Options - Right to Buy | D | 1,41 | 100.000 | 100.000 | |||||
2022-03-31 | 2022-03-29 | 4 | Moses Alan Charles | PHGE | Common Stock Options - Right to Buy | D | 1,41 | 20.500 | 20.500 | |||||
2022-02-14 | 2021-12-31 | 4 | Walton Thomas Layton By SymBiosis, LLC | PHGE | Warrants to purchase Common Stock | I | 5,00 | -1.875.000 | 0 | |||||
2022-02-14 | 2021-12-31 | 4 | Walton Thomas Layton By SymBiosis, LLC | PHGE | Common Stock, $0.0001 par value | I | -3.637.846 | 0 | ||||||
2022-02-14 | 3 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 3.637.846 | ||||||||
2021-08-17 | 2021-07-26 | 4/A | GROSSMAN JONAS | PHGE | Common Stock, par value $0.0001 | D | 37.500 | 372.717 | ||||||
2021-08-17 | 2020-07-26 | 4/A | GROSSMAN JONAS | PHGE | Warrants to purchase Common Stock | D | 5,00 | 28.125 | 28.125 | |||||
2021-08-09 | 3 | Walton Thomas Layton By SymBiosis, LLC | PHGE | Common Stock, $0.0001 par value | I | 3.637.846 | ||||||||
2021-07-30 | 2021-07-28 | 4 | OrbiMed Israel BioFund GP Limited Partnership See Footnotes | PHGE | Warrants (Right to Buy) | I | 5,00 | 375.000 | 375.000 | |||||
2021-07-30 | 2021-07-28 | 4 | OrbiMed Israel BioFund GP Limited Partnership See Footnotes | PHGE | Common Stock, $0.0001 par value | I | 500.000 | 2.813.489 | ||||||
2021-07-30 | 2021-07-28 | 4 | Wolfson Marina | PHGE | Common Stock Warrant | D | 5,00 | 2.813 | 2.813 | |||||
2021-07-30 | 2021-07-28 | 4 | Wolfson Marina | PHGE | Common Stock | D | 4,0000 | 3.750 | 15 | 3.750 | ||||
2021-07-30 | 2021-07-28 | 4 | Sullivan Lynne Marie | PHGE | Common Stock Warrant | D | 5,00 | 9.375 | 9.375 | |||||
2021-07-30 | 2021-07-28 | 4 | Sullivan Lynne Marie | PHGE | Common Stock | D | 4,0000 | 12.500 | 50 | 12.500 | ||||
2021-07-30 | 2021-07-28 | 4 | Solomon Jonathan Eitan | PHGE | Common Stock Warrant | D | 5,00 | 18.750 | 18.750 | |||||
2021-07-30 | 2021-07-28 | 4 | Solomon Jonathan Eitan | PHGE | Common Stock | D | 4,0000 | 25.000 | 100 | 25.000 | ||||
2021-07-30 | 2021-07-28 | 4 | SEKHRI PAUL J | PHGE | Common Stock Warrant | D | 5,00 | 9.375 | 9.375 | |||||
2021-07-30 | 2021-07-28 | 4 | SEKHRI PAUL J | PHGE | Common Stock | D | 4,0000 | 12.500 | 50 | 12.500 | ||||
2021-07-30 | 2021-07-28 | 4 | Greig Russell | PHGE | Common Stock Warrant | I | 5,00 | 2.813 | 2.813 | |||||
2021-07-30 | 2021-07-28 | 4 | Greig Russell | PHGE | Common Stock | I | 4,0000 | 3.750 | 15 | 3.750 | ||||
2021-07-30 | 2021-07-28 | 4 | Moses Alan Charles | PHGE | Common Stock Warrant | D | 5,00 | 3.750 | 3.750 | |||||
2021-07-30 | 2021-07-28 | 4 | Moses Alan Charles | PHGE | Common Stock | D | 4,0000 | 5.000 | 20 | 5.000 | ||||
2021-07-28 | 2021-07-26 | 4 | GROSSMAN JONAS | PHGE | Warrants to purchase Common Stock | D | 5,00 | 28.125 | 28.125 | |||||
2021-07-28 | 2021-07-26 | 4 | GROSSMAN JONAS | PHGE | Common Stock, par value $0.0001 | D | 37.500 | 372.217 | ||||||
2021-07-28 | 2021-07-26 | 4 | Amusa Gbolahan | PHGE | Warrants to purchase Common Stock | D | 5,00 | 18.750 | 18.750 | |||||
2021-07-28 | 2021-07-26 | 4 | Amusa Gbolahan | PHGE | Common Stock, par value $0.0001 | D | 25.000 | 262.871 | ||||||
2021-04-01 | 2021-03-30 | 4 | Puttagunta Sailaja | PHGE | Common Stock Options - Right to Buy | D | 7,02 | 71.250 | 71.250 | |||||
2021-04-01 | 2021-03-30 | 4 | Greig Russell | PHGE | Common Stock Options - Right to Buy | D | 7,02 | 30.400 | 30.400 | |||||
2021-04-01 | 2021-03-30 | 4 | SEKHRI PAUL J | PHGE | Common Stock Options - Right to Buy | D | 7,02 | 15.200 | 15.200 | |||||
2021-04-01 | 2021-03-30 | 4 | Oron Assaf | PHGE | Common Stock Options - Right to Buy | D | 7,02 | 33.250 | 33.250 | |||||
2021-04-01 | 2021-03-30 | 4 | Moses Alan Charles | PHGE | Common Stock Options - Right to Buy | D | 7,02 | 15.200 | 15.200 | |||||
2021-04-01 | 2021-03-30 | 4 | Bassan Merav | PHGE | Common Stock Options - Right to Buy | D | 7,02 | 47.500 | 47.500 | |||||
2021-04-01 | 2021-03-30 | 4 | Wolfson Marina | PHGE | Common Stock Options - Right to Buy | D | 7,02 | 33.250 | 33.250 | |||||
2021-04-01 | 2021-03-30 | 4 | Sullivan Lynne Marie | PHGE | Common Stock Options - Right to Buy | D | 7,02 | 15.200 | 15.200 | |||||
2021-04-01 | 2021-03-30 | 4 | Solomon Jonathan Eitan | PHGE | Common Stock Options - Right to Buy | D | 7,02 | 152.000 | 152.000 | |||||
2021-04-01 | 2021-03-30 | 4 | GROSSMAN JONAS | PHGE | Common Stock Options - Right to Buy | D | 7,02 | 15.200 | 15.200 | |||||
2021-04-01 | 2021-03-30 | 4 | Amusa Gbolahan | PHGE | Common Stock Options - Right to Buy | D | 7,02 | 15.200 | 15.200 | |||||
2020-10-05 | 2020-10-02 | 4 | SEKHRI PAUL J | PHGE | Common Stock Options - Right to Buy | D | 6,44 | 16.000 | 16.000 | |||||
2020-10-05 | 2020-10-02 | 4 | Moses Alan Charles | PHGE | Common Stock Options - Right to Buy | D | 6,44 | 16.000 | 16.000 | |||||
2020-07-27 | 2020-07-13 | 4 | Amusa Gbolahan | PHGE | Warrants to purchase Common Stock | D | 11,50 | 276.190 | 276.190 | |||||
2020-07-27 | 2020-07-13 | 4 | Amusa Gbolahan | PHGE | Common Stock, par value $0.0001 | D | 95.148 | 237.871 | ||||||
2020-07-22 | 2020-07-13 | 4 | PROPPER KERRY By Mountain Wood, LLC | PHGE | Warrants to purchase Common Stock | I | 11,50 | -2.900.000 | 0 | |||||
2020-07-22 | 2020-07-13 | 4 | PROPPER KERRY | PHGE | Warrants to purchase Common Stock | D | 11,50 | 631.786 | 631.786 | |||||
2020-07-22 | 2020-07-13 | 4 | PROPPER KERRY By Mountain Wood, LLC | PHGE | Common Stock, par value $0.0001 | I | -999.058 | 0 | ||||||
2020-07-22 | 2020-07-13 | 4 | PROPPER KERRY | PHGE | Common Stock, par value $0.0001 | D | 217.652 | 260.771 | ||||||
2020-07-22 | 2020-07-13 | 4 | GROSSMAN JONAS | PHGE | Warrants to purchase Common Stock | D | 11,50 | 666.310 | 716.439 | |||||
2020-07-22 | 2020-07-13 | 4 | GROSSMAN JONAS | PHGE | Common Stock, par value $0.0001 | D | 229.545 | 335.217 | ||||||
2020-07-22 | 2020-06-18 | 4 | GROSSMAN JONAS By Ravenna LLC | PHGE | Common Stock, par value $0.0001 | I | -45.275 | 0 | ||||||
2020-06-12 | 2020-06-10 | 4 | PROPPER KERRY By Mountain Wood, LLC | PHGE | Common Stock, par value $0.0001 | I | 999.058 | 999.058 | ||||||
2020-06-12 | 2020-06-10 | 4 | PROPPER KERRY | PHGE | Common Stock, par value $0.0001 | D | 43.119 | 43.119 | ||||||
2020-06-12 | 2020-06-10 | 4 | Amusa Gbolahan | PHGE | Common Stock, par value $0.0001 | D | 142.723 | 142.723 | ||||||
2020-06-12 | 2020-06-10 | 4 | GROSSMAN JONAS By Ravenna LLC | PHGE | Common Stock, par value $0.0001 | I | 42.275 | 45.275 | ||||||
2020-06-12 | 2020-06-10 | 4 | GROSSMAN JONAS By Chardan Investments, LLC | PHGE | Common Stock, par value $0.0001 | I | -1.707.500 | 0 | ||||||
2020-06-12 | 2020-06-10 | 4 | GROSSMAN JONAS | PHGE | Common Stock, par value $0.0001 | D | 99.172 | 105.672 | ||||||
2020-03-27 | 2020-03-25 | 4 | Solomon Jonathan Eitan | PHGE | Common Stock Options - Right to Buy | D | 6,21 | 144.000 | 144.000 | |||||
2020-03-27 | 2020-03-25 | 4 | GROSSMAN JONAS | PHGE | Common Stock Options - Right to Buy | D | 6,21 | 16.000 | 16.000 | |||||
2020-03-27 | 2020-03-25 | 4 | Chimovits Erez | PHGE | Common Stock Options - Right to Buy | D | 6,21 | 16.000 | 16.000 | |||||
2020-03-27 | 2020-03-25 | 4 | Amusa Gbolahan | PHGE | Common Stock Options - Right to Buy | D | 6,21 | 16.000 | 16.000 | |||||
2020-03-27 | 2020-03-25 | 4 | Oron Assaf | PHGE | Common Stock Options - Right to Buy | D | 6,21 | 31.500 | 31.500 | |||||
2020-03-27 | 2020-03-25 | 4 | Sullivan Lynne Marie | PHGE | Common Stock Options - Right to Buy | D | 6,21 | 16.000 | 16.000 | |||||
2020-03-27 | 2020-03-25 | 4 | Breski Yaron | PHGE | Common Stock Options - Right to Buy | D | 6,21 | 16.000 | 16.000 | |||||
2020-03-27 | 2020-03-25 | 4 | Wolfson Marina | PHGE | Common Stock Options - Right to Buy | D | 6,21 | 36.000 | 36.000 | |||||
2020-03-27 | 2020-03-25 | 4 | Puttagunta Sailaja | PHGE | Common Stock Options - Right to Buy | I | 6,21 | 67.500 | 67.500 | |||||
2020-03-27 | 2020-03-25 | 4 | Greig Russell | PHGE | Common Stock Options - Right to Buy | D | 6,21 | 32.000 | 32.000 | |||||
2019-12-30 | 2019-12-20 | 4 | GROSSMAN JONAS | PHGE | Warrants | I | 11,50 | -2.900.000 | 0 | |||||
2019-12-20 | 2019-12-19 | 4 | Chimovits Erez See Footnotes | PHGE | Common Stock, $0.001 par value | I | 8,9000 | 3.500 | 31 | 2.313.489 | ||||
2019-12-20 | 2019-12-18 | 4 | Chimovits Erez See Footnotes | PHGE | Common Stock, $0.001 par value | I | 8,9300 | 500 | 4 | 2.309.989 | ||||
2019-12-20 | 2019-12-19 | 4 | OrbiMed Israel BioFund GP Limited Partnership See Footnotes | PHGE | Common Stock, $0.001 par value | I | 8,9000 | 3.500 | 31 | 2.313.489 | ||||
2019-12-20 | 2019-12-18 | 4 | OrbiMed Israel BioFund GP Limited Partnership See Footnotes | PHGE | Common Stock, $0.001 par value | I | 8,9300 | 500 | 4 | 2.309.989 | ||||
2019-12-12 | 2019-12-11 | 4 | OrbiMed Israel BioFund GP Limited Partnership See Footnotes | PHGE | Common Stock, $0.001 par value | I | 8,9200 | 5.400 | 48 | 2.309.489 | ||||
2019-12-12 | 2019-12-10 | 4 | OrbiMed Israel BioFund GP Limited Partnership See Footnotes | PHGE | Common Stock, $0.001 par value | I | 8,7500 | 3.400 | 30 | 2.304.089 | ||||
2019-12-12 | 2019-12-11 | 4 | Chimovits Erez See Footnotes | PHGE | Common Stock, $0.001 par value | I | 8,9200 | 5.400 | 48 | 2.309.489 | ||||
2019-12-12 | 2019-12-10 | 4 | Chimovits Erez See Footnotes | PHGE | Common Stock, $0.001 par value | I | 8,7500 | 3.400 | 30 | 2.304.089 | ||||
2019-12-09 | 2019-12-09 | 4 | OrbiMed Israel BioFund GP Limited Partnership See Footnotes | PHGE | Common Stock, $0.001 par value | I | 8,6800 | 6.000 | 52 | 2.300.689 | ||||
2019-12-09 | 2019-12-06 | 4 | OrbiMed Israel BioFund GP Limited Partnership See Footnotes | PHGE | Common Stock, $0.001 par value | I | 8,0000 | 800 | 6 | 2.294.689 | ||||
2019-12-09 | 2019-12-05 | 4 | OrbiMed Israel BioFund GP Limited Partnership See Footnotes | PHGE | Common Stock, $0.001 par value | I | 7,9900 | 3.400 | 27 | 2.293.889 | ||||
2019-12-09 | 2019-12-09 | 4 | Chimovits Erez See Footnotes | PHGE | Common Stock, $0.001 par value | I | 8,6800 | 6.000 | 52 | 2.300.689 | ||||
2019-12-09 | 2019-12-06 | 4 | Chimovits Erez See Footnotes | PHGE | Common Stock, $0.001 par value | I | 8,0000 | 800 | 6 | 2.294.689 | ||||
2019-12-09 | 2019-12-05 | 4 | Chimovits Erez See Footnotes | PHGE | Common Stock, $0.001 par value | I | 7,9900 | 3.400 | 27 | 2.293.889 | ||||
2019-11-20 | 2019-11-20 | 4 | GROSSMAN JONAS | PHGE | Common Stock, par value $0.0001 | D | 8,0040 | 1.400 | 11 | 6.500 | ||||
2019-11-20 | 2019-11-19 | 4 | GROSSMAN JONAS | PHGE | Common Stock, par value $0.0001 | D | 7,5730 | 4.100 | 31 | 5.100 | ||||
2019-11-20 | 2019-11-18 | 4 | GROSSMAN JONAS | PHGE | Warrants | D | 11,50 | 0,5990 | 50.129 | 30 | 50.129 | |||
2019-11-20 | 2019-11-18 | 4 | GROSSMAN JONAS | PHGE | Common Stock, par value $0.0001 | D | 6,9890 | 1.000 | 7 | 1.000 | ||||
2019-11-07 | 3 | Chimovits Erez See Footnotes | PHGE | Common Stock | I | 4.580.980 | ||||||||
2019-11-07 | 3 | Chimovits Erez See Footnotes | PHGE | Common Stock | I | 4.580.980 | ||||||||
2019-11-07 | 3 | Chimovits Erez See Footnotes | PHGE | Common Stock | I | 4.580.980 | ||||||||
2019-11-07 | 3 | OrbiMed Israel GP Ltd. See Footnotes | PHGE | Common Stock | I | 4.580.980 | ||||||||
2019-11-07 | 3 | OrbiMed Israel GP Ltd. See Footnotes | PHGE | Common Stock | I | 4.580.980 | ||||||||
2019-11-07 | 3 | OrbiMed Israel GP Ltd. See Footnotes | PHGE | Common Stock | I | 4.580.980 | ||||||||
2019-11-07 | 3 | OrbiMed Israel GP Ltd. See Footnotes | PHGE | Common Stock | I | 4.580.980 | ||||||||
2019-11-05 | 3 | Takeda Ventures, Inc. | PHGE | Common Stock | I | 4.941.870 | ||||||||
2019-11-05 | 3 | Takeda Ventures, Inc. | PHGE | Common Stock | I | 4.941.870 | ||||||||
2019-11-05 | 3 | Takeda Ventures, Inc. | PHGE | Common Stock | I | 4.941.870 | ||||||||
2019-11-05 | 3 | Takeda Ventures, Inc. | PHGE | Common Stock | I | 4.941.870 | ||||||||
2019-09-19 | 3 | MMCAP International Inc. SPC | CHAC | Common Stock | D | 3.400.000 | ||||||||
2019-09-19 | 3 | MMCAP International Inc. SPC | CHAC | Common Stock | D | 3.400.000 | ||||||||
2019-09-19 | 3 | MMCAP International Inc. SPC | CHAC | Common Stock | D | 3.400.000 | ||||||||
2018-12-21 | 3 | Gnedy Elliot | CHAC | Common Stock, par value $0.0001 | D | 15.000 | ||||||||
2018-12-21 | 3 | Gnedy Elliot | CHAC | Common Stock, par value $0.0001 | D | 15.000 | ||||||||
2018-12-21 | 3 | Gnedy Elliot | CHAC | Common Stock, par value $0.0001 | D | 15.000 | ||||||||
2018-12-19 | 2018-12-18 | 4 | GROSSMAN JONAS | CHAC | Warrants | I | 11,50 | 0,4000 | 2.900.000 | 1.160 | 2.900.000 | |||
2018-12-14 | 3 | Kusseluk Eric | CHAC | Common Stock, par value $0.0001 | D | 15.000 | ||||||||
2018-12-14 | 3 | Kusseluk Eric | CHAC | Common Stock, par value $0.0001 | D | 15.000 | ||||||||
2018-12-14 | 3 | Kusseluk Eric | CHAC | Common Stock, par value $0.0001 | D | 15.000 | ||||||||
2018-12-14 | 3 | GROSSMAN JONAS | CHAC | Common Stock, par value $0.0001 | I | 3.940.000 | ||||||||
2018-12-14 | 3 | GROSSMAN JONAS | CHAC | Common Stock, par value $0.0001 | I | 3.940.000 | ||||||||
2018-12-14 | 3 | GROSSMAN JONAS | CHAC | Common Stock, par value $0.0001 | I | 3.940.000 | ||||||||
2018-12-14 | 3 | Rossen Matthew | CHAC | Common Stock, par value $0.0001 | D | 15.000 | ||||||||
2018-12-14 | 3 | Rossen Matthew | CHAC | Common Stock, par value $0.0001 | D | 15.000 | ||||||||
2018-12-14 | 3 | Rossen Matthew | CHAC | Common Stock, par value $0.0001 | D | 15.000 | ||||||||
2018-12-14 | 3 | RICE YEHUDA MICHAEL | CHAC | Common Stock, par value $0.0001 | D | 15.000 | ||||||||
2018-12-14 | 3 | RICE YEHUDA MICHAEL | CHAC | Common Stock, par value $0.0001 | D | 15.000 | ||||||||
2018-12-14 | 3 | RICE YEHUDA MICHAEL | CHAC | Common Stock, par value $0.0001 | D | 15.000 | ||||||||
2018-12-14 | 3 | Chardan Investments, LLC | CHAC | Common Stock, par value $0.0001 | D | 3.940.000 | ||||||||
2018-12-14 | 3 | Chardan Investments, LLC | CHAC | Common Stock, par value $0.0001 | D | 3.940.000 | ||||||||
2018-12-14 | 3 | Chardan Investments, LLC | CHAC | Common Stock, par value $0.0001 | D | 3.940.000 | ||||||||
2018-12-14 | 3 | Giroux Richard | CHAC | Common Stock, par value $0.0001 | D | 15.000 | ||||||||
2018-12-14 | 3 | Giroux Richard | CHAC | Common Stock, par value $0.0001 | D | 15.000 | ||||||||
2018-12-14 | 3 | Giroux Richard | CHAC | Common Stock, par value $0.0001 | D | 15.000 |